Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07007078
EARLY_PHASE1

Efficacy of Dihydroartemisinin for Treating Acne Vulgaris

Sponsor: Shanghai Zhongshan Hospital

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Acne Vulgaris in adults. The main question it aims to answer is: • Does DHA improve the acne severity by at least one grade after treatment. Researchers will treat patients who are clinically diagnosed as Acne Vulgaris to see if DHA works to alleviate the symptoms of Acne Vulgaris. Participants will: * Take DHA every day for 3 months * Visit the clinic once every month for checkups and tests

Official title: A Pilot Study to Evaluate the Therapeutic Effect of Dihydroartemisinin on Acne Vulgaris

Key Details

Gender

All

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-06

Completion Date

2026-12

Last Updated

2025-06-05

Healthy Volunteers

No

Conditions

Interventions

DRUG

dihydroartemisinin

DHA 40mg tid for 90 days

Locations (1)

Zhongshan Hospital Fudan University

Shanghai, Shanghai Municipality, China